While myelofibrosis (MF) is a rare and complex blood cancer, scientific innovation is continuously driving new hope for MF patients and those who care for them. Traditional approaches have focused on managing symptoms, but the future looks toward advanced combination therapies designed to address the deeper biological causes of the disease and improve long-term well-being. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Today marks World Cancer Research Day, a time to recognize the discoveries, collaborations and scientific advancements that continue to move cancer research forward. We are grateful to the researchers, healthcare professionals, patients, and advocates whose dedication fuels progress and creates hope for the future. #WorldCancerResearchDay #CancerResearch #Oncology #MenariniStemline

Did you know that Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is most commonly diagnosed in adults between the ages of 60 and 70? While BPDCN can affect both men and women, approximately 75% of cases occur in men. During Blood Cancer Awareness Month, we're highlighting the importance of greater understanding and recognition of rare blood cancers like BPDCN. Learn more about BPDCN at bpdcninfo.com. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Our team was pleased to join the international pathology community at the European Society of Pathology (ESP) Congress in Stockholm. It was a valuable few days of scientific exchange and connection with colleagues dedicated to advancing biomarker testing and improving care for patients worldwide. #MenariniStemline

Multiple myeloma accounts for 10–15% of all blood cancers, with ~188,000 cases diagnosed globally each year. Over the past 20 years, survival outcomes for multiple myeloma have improved substantially, thanks to incredible medical innovations. While it remains a complex blood cancer, the oncology community, including Menarini Stemline, is fighting back by advancing research and supporting patients with this disease. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Thank you to everyone who visited the Menarini Stemline booths at #SOHO2026! It was energizing to connect with the global hematology community and discuss the latest advancements in blood cancer research and patient care. #MenariniStemline

This Blood Cancer Awareness Month, we're helping raise awareness of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), an aggressive orphan blood cancer. Although BPDCN can affect multiple parts of the body, it most commonly involves the skin, bone marrow, and blood. Learn more about BPDCN at bpdcninfo.com. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Happy Labor Day from Menarini Stemline. Today we recognize the dedication, talent, and hard work of our colleagues, as well as workers across our communities whose contributions make a difference every day. Thank you for all that you do! #LaborDay #MenariniStemline

On World Leukemia Day, we stand with the global community to raise awareness and underscore the vital need for continued research. Our commitment to scientific innovation is driven by the patients and families we serve. Together, we can work toward a future with better outcomes for those affected by blood cancer. #WorldLeukemiaDay #LeukemiaAwareness #BloodCancer #Oncology #MenariniStemline

The Menarini Stemline team is looking forward to the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting, where we will connect with scientific leaders and share our ongoing commitment to advancing research for patients living with blood cancers. If you're attending #SOHO2026, stop by to meet our team. #MenariniStemline

This September, Menarini Stemline proudly joins the global community in recognizing Blood Cancer Awareness Month. Blood cancers impact millions of people worldwide and underscore the continued need for research, innovation, new therapeutic options, and education. Throughout the month, we’ll be sharing information to help raise awareness and shine a light on the patients, caregivers, healthcare professionals, and researchers working relentlessly to drive vital advances in blood cancer. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

As we wrap up another successful summer internship program, we'd like to recognize and thank our 2026 interns for the energy, dedication, and fresh perspectives they brought to Menarini Stemline. From supporting projects across the business to learning from colleagues throughout the organization, our interns made meaningful contributions while gaining valuable professional experience along the way. Thank you for being part of our team this summer. We can't wait to see what's next for each of you. #MenariniStemline #InternshipProgram

Today, on World Breast Cancer Research Day, we recognize the scientists, healthcare professionals, advocates, patients and care partners whose contributions continue to advance progress against breast cancer. Research remains essential to improving outcomes and expanding possibilities for people affected by this disease. We are proud to support the medical community’s ongoing efforts to deepen our scientific understanding of breast cancer and help address crucial patient needs. #WorldBreastCancerResearchDay #Oncology #MenariniStemline

Identifying ESR1 mutations is crucial in managing advanced or metastatic ER+/HER2- breast cancer. As the tumor evolves, understanding these molecular shifts is essential to determining the next line of therapy. Visit knowesr1.com to learn how identifying an ESR1 mutation impacts clinical decisions. #Oncology #MenariniStemline

At Menarini Stemline, supporting our communities is an important part of who we are. Recently, members of our team volunteered their time to help prepare students for the upcoming school year by assembling backpacks filled with essential supplies. We’re proud to support local families and we extend our thanks to Operation Backpack for the opportunity to contribute to the next generation’s success. Thank you to everyone who participated! #MenariniStemline #OperationBackpack #CommunityImpact

On #NationalInternDay, we’re recognizing our interns and the impact they’ve made across Menarini Stemline. From jumping into projects to bringing new ideas and perspectives to the team, they’ve been a valuable part of the summer. Now, as they get ready for their final presentations, we’re excited to see everything they’ve accomplished and learned during their internship experience. Thank you to our interns for all of your hard work, and to the teams who took the time to mentor and support them along the way. #MenariniStemline #InternshipProgram

We recently brought together cross-functional colleagues from across the Asia-Pacific region—including Hong Kong, Singapore, Malaysia, Brunei, South Korea, Australia, and Taiwan—for a regional gathering focused on collaboration and continuous learning. Empowering our regional teams through shared insights and cross-functional alignment ensures we continue to deliver the highest standard of excellence to the patients we serve. Thank you, all, for bringing  your passion and dedication to the table! #MenariniStemline

Biomarker testing is a critical tool for navigating the complexities of advanced ER+/HER2- breast cancer. As tumors evolve, identifying ESR1 mutations can help guide treatment decisions. Visit knowesr1.com to hear Dr. VK Gadi explain the importance of timely testing and its potential impact on personalized care. #Oncology #MenariniStemline

Wishing a safe and happy 4th of July to all our Menarini Stemline colleagues, partners, and friends celebrating in the United States! #IndependenceDay #MenariniStemline

For those living with myelofibrosis, the impact is more than just a diagnosis—it’s a daily struggle. Most patients present with two or more debilitating symptoms at diagnosis, ranging from bone pain to extreme fatigue. At Menarini Stemline, we are committed to addressing the unmet needs of the myelofibrosis community. #Myelofibrosis #MenariniStemline